title: The sst1 resistance locus regulates evasion of type I interferon signaling by Chlamydia pneumoniae as a disease tolerance mechanism.
abstract: The sst1, "supersusceptibility to tuberculosis," locus has previously been shown to be a genetic determinant of host resistance to infection with the intracellular pathogen, Mycobacterium tuberculosis. Chlamydia pneumoniae is an obligate intracellular bacterium associated with community acquired pneumonia, and chronic infection with C. pneumoniae has been linked to asthma and atherosclerosis. C. pneumoniae is a highly adapted pathogen that can productively infect macrophages and inhibit host cell apoptosis. Here we examined the role of sst1 in regulating the host response to infection with C. pneumoniae. Although mice carrying the sst1 susceptible (sst1(S) ) locus were not impaired in their ability to clear the acute infection, they were dramatically less tolerant of the induced immune response, displaying higher clinical scores, more severe lung inflammation, exaggerated macrophage and neutrophil influx, and the development of fibrosis compared to wild type mice. This correlated with increased activated caspase-3 in the lungs of infected sst1(S) mice. Infection of sst1(S) macrophages with C. pneumoniae resulted in a shift in the secreted cytokine profile towards enhanced production of interferon-β and interleukin-10, and induced apoptotic cell death, which was dependent on secretion of interferon-β. Intriguingly macrophages from the sst1(S) mice failed to support normal chlamydial growth, resulting in arrested development and failure of the organism to complete its infectious cycle. We conclude that the sst1 locus regulates a shared macrophage-mediated innate defense mechanism against diverse intracellular bacterial pathogens. Its susceptibility allele leads to upregulation of type I interferon pathway, which, in the context of C. pneumoniae, results in decreased tolerance, but not resistance, to the infection. Further dissection of the relationship between type I interferons and host tolerance during infection with intracellular pathogens may provide identification of biomarkers and novel therapeutic targets.
authors.affiliation: Section of Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, United States of America.
authors.forename: Xianbao
authors.initials: X
authors.lastname: He
authors.forename: Robert
authors.initials: R
authors.lastname: Berland
authors.forename: Samrawit
authors.initials: S
authors.lastname: Mekasha
authors.forename: Thomas G
authors.initials: TG
authors.lastname: Christensen
authors.forename: Joseph
authors.initials: J
authors.lastname: Alroy
authors.forename: Igor
authors.initials: I
authors.lastname: Kramnik
authors.forename: Robin R
authors.initials: RR
authors.lastname: Ingalls
mesh_terms: D000818:Animals; D053148:Caspase 3 / Q000235:genetics / Q000276:immunology; D023521:Chlamydophila Infections / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D016993:Chlamydophila pneumoniae / Q000235:genetics / Q000276:immunology* / Q000648:ultrastructure; D056426:Genetic Loci / Q000276:immunology*; D057131:Immune Evasion / Q000235:genetics; D007113:Immunity, Innate / Q000502:physiology*; D016899:Interferon-beta / Q000235:genetics / Q000276:immunology; D016753:Interleukin-10 / Q000235:genetics / Q000276:immunology; D016676:Macrophages, Alveolar / Q000276:immunology* / Q000648:ultrastructure; D051379:Mice; D018410:Pneumonia, Bacterial / Q000235:genetics / Q000276:immunology* / Q000473:pathology
chemical_list: C556062:IL10 protein, mouse; D016753:Interleukin-10; D016899:Interferon-beta; C505409:Casp3 protein, mouse; D053148:Caspase 3